Infants colonized with enterotoxin-producing staphylococci at 3 months display a decreased frequency of interferon-γ-producing CD45RO lymphocytes upon stimulation with staphylococcal enterotoxin A at birth but not at 6 months of age

Pediatric Allergy and Immunology

Volumn 10, Issue 4, 1999, Pages 241-248

  Schauer, Uwe ^a   Thurau, Anja ^a   Seitz, Miriam ^a   Nowak, Lars ^a   Petri, Holger ^a   Leinhaas, Claudia ^a   Rieger, Christian ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

Antigens; CD45 immunology; Enterotoxins; Infant; Interferon type II; Interleukin 2; Interleukin 4; Interleukin 5; Staphylococcus aureus

Indexed keywords

CD45 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; STAPHYLOCOCCUS ENTEROTOXIN; STAPHYLOCOCCUS ENTEROTOXIN A; CD45RO ANTIGEN; PHORBOL MYRISTATE;

ANTIGEN EXPRESSION; ARTICLE; ATOPY; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PRIORITY JOURNAL; RISK FACTOR; STAPHYLOCOCCUS; T LYMPHOCYTE; UMBILICAL CORD BLOOD; CELL STIMULATION; COMPARATIVE STUDY; CYTOKINE RESPONSE; ENVIRONMENTAL FACTOR; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTE; MEMORY CELL; NONHUMAN; PROTEIN EXPRESSION;

AGE FACTORS; ANTIGENS, CD45; ENTEROTOXINS; FEMALE; FETAL BLOOD; HUMANS; INFANT; INFANT, NEWBORN; INTERFERON TYPE II; INTERLEUKIN-4; INTERLEUKIN-5; LYMPHOCYTE ACTIVATION; MALE; NOSE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; T-LYMPHOCYTE SUBSETS;

EID: 0033374957     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3038.1999.00035.x     Document Type: Article

References (34)

1. CARRATELLI CR, NUZZO I, BENTIVOGLIO C, GALDIERO M. CD11a/CD18 and CD11b/18 modulation by lipoteichoic acid, N-acetyl-muramyl-alpha-alanyl-D-isoglutamine, muramic acid and protein A from Staphylococcus aureus. FEMS Immunol Med Microbiol 1996: 16: 309-15.
2. LEUNG DY, SULLIVAN KE, BROWN-WHITEHORN TF, et al. Association of toxic shock syndrome toxin-secreting and exfoliative toxin-secreting Staphylococcus aureus with Kawasaki syndrome complicated by coronary artery disease. Pediatr Res 1997: 42: 268-72.
3. CAMPBEEL DE, KEMP AS. Proliferation and production of interferon-gamma (IFN-gamma) and IL-4 in response to Staphylococcus aureus and staphylococcal superantigen in childhood atopic dermatitis. Clin Exp Immunol 1997: 107: 392-7.
4. MALAM JE, CARRICK GF, TELFORD DR, MORRIS JA. Staphylococcal toxins and sudden infant death syndrome. J Clin Pathol 1992: 45: 716-21.
5. KLUYTMANS J, VAN BELKUM A, VERBRUGH H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997: 10: 505-20.
6. MARRACK P, KAPPLER J. The staphylococcal enterotoxins and their relatives. Science 1990: 248: 705-11.
7. ERTEL W, KEEL M, NEIDHARDT R, et al. Inhibition of the defense system stimulating interleukin-12 Interferon-gamma pathway during critical illness. Blood 1997: 89: 1612-20.
8. LEE W, VITETTA E. Memory T cells are anergic to the superantigen staphylococcal enterotoxin B. J Exp Med 1992: 176: 575-9.
9. BEER AE, BILLINGHAM RE. Immunobiology of mammalian reproduction. Adv Immunol 1971: 14: 1-84.
10. WILSON CB. Immunologic basis for increased susceptibility of the neonate to infection. J Pediatr 1986: 108: 1-12.
11. ZDRAZILEK J, PETRAS P, SRAMOVA H, SUBERTOVA V, MASKOVA L. Staphylococcus aureus at a maternity ward. I. Colonization of mothers and neonates and survival of various S. aureus types in colonized individuals. J Hyg Epidemiol Microbiol Immunol 1988: 32: 49-57.
12. MIYAWAKI T, SEKI H, TAGA K, SATO H, TANIGUCHI N. Dissociated production of interleukin-2 and immune (gamma) interferon by phytohaemagglutinin stimulated lymphocytes in healthy infants. Clin Exp Immunol 1985: 59: 505-11.
13. WAKASUGI N, VIRELIZIER JL, ARENZANA SEISDEDOS F, ROTHHUT B, HUERTA JM, RUSSO MARIE F, FIERS W. Defective IFN-gamma production in the human neonate. II. Role of increased sensitivity to the suppressive effects of prostaglandin E. J Immunol 1985: 134: 172-6.
14. BERGMANN RL, FORSTER J, SCHULZ J, BERGMANN KE, BAUER CP, WAHN U. Atopic family history. Validation of instruments in a multicenter cohort study. Pediatr Allergy Immunol 1993: 4: 130-5.
15. JUNG T, SCHAUER U, HEUSSER C, NEUMANN C, RIEGER C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993: 159: 197-207.
16. MICHIE C, HARVEY D. Can expression of CD45RO, a T-cell surface molecule, be used to detect congenital infection? [see comments]. Lancet 1994: 343: 1259-60.
17. TEZUKA T, SUGITA K, MIZOBE N, et al. Transient increase in CD45RO expression on T lymphocytes in infected newborns. Pediatr Res 1998: 43: 283-90.
18. BURR ML, HOWELLS CH, REES PW. Antibiotic resistant staphylococci acquired during the first year of life. J Hyg (Lond) 1978: 81: 125-30.
19. ANDO T, YOSHIKAI Y, MATSUZAKI G, TAKIMOTO H, NOMOTO K. The stage of negative selection in tolerance induction in neonatal mice. Immunology 1991: 74: 638-44.
20. TAKAHASHI N, IMANISHI K, NISHIDA H, UCHIYAMA T. Evidence for immunologic immaturity of cord blood T cells. Cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a superantigen. J Immunol 1995: 155: 5213-9.
21. MIETHKE T, WAHL C, GAUS H, HEEG K, WAGNER H. Exogenous superantigens acutely trigger distinct levels of peripheral T cell tolerance/immunosuppression: dose-response relationship. Eur J Immunol 1994: 24: 1893-902.
22. METZGER R, MELMER G, SCHONDELMAIER S, et al. Leukaemic T cells from patients with chronic lymphocytic leukaemia of T-cell origin respond to Staphylococcus aureus enterotoxin superantigens. Scand J Immunol 1993: 37: 245-50.
23. OGATA M, KIKUCHI H, OHTSUKA E, KOHNO K, ITO M, NASU M. Stimulation of leukaemic cells from adult T-cell leukaemia patients with bacterial superantigens. Br J Haematol 1998: 100: 490-500.
24. HAYWARD A, COSYNS M. Proliferative and cytokine responses by human newborn T cells stimulated with staphylococcal enterotoxin B. Pediatr Res 1994: 35: 293-8.
25. WU CY, DEMEURE C, KINIWA M, GATELY M, DELESPESSE G. IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells. J Immunol 1993: 151: 1938-49.
26. SAHA B, HARLAN DM, LEE KP, JUNE CH, ABE R. Protection against lethal toxic shock by targeted disruption of the CD28 gene. J Exp Med 1996: 183: 2675-80.
27. MITTRUCKER HW, SHAHINIAN A, BOUCHARD D, KUNDIG TM, MAK TW. Induction of unresponsiveness and impaired T cell expansion by staphylococcal enterotoxin B in CD28-deficient mice. J Exp Med 1996: 183: 2481-8.
28. SUNDSTEDT A, HOIDEN I, ROSENDAHL A, KALLAND T, VAN ROOIJEN N, DOHLSTEN M. Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo. J Immunol 1997: 158: 180-6.
29. HUNT DW, HUPPERTZ HI, JIANG HJ, PETTY RE. Studies of human cord blood dendritic cells: evidence for functional immaturity. Blood 1994: 84: 4333-43.
30. NELSON DJ, HOLT PG. Defective regional immunity in the respiratory tract of neonates is attributable to hyporesponsiveness of local dendritic cells to activation signals. J Immunol 1995: 155: 3517-24.
31. CELLA M, SALLUSTO F, LANZAVECCHIA A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997: 9: 10-6.
32. OHSHIMA Y, DELESPESSE G. T cell-derived IL-4 and dendritic cell-derived IL-12 regulate the lymphokine-producing phenotype of alloantigen-primed naive human CD4 T cells. J Immunol 1997: 158: 629-36.
33. WARNER JA, JONES AC, MILES EA, WARNER JO. Prenatal scnsitisation. Pediatr Allergy Immunol 1996: 7 (Suppl. 9): 98-101.
34. POHL D, BOCKELMANN C, FORSTER K, RIEGER CH, SCHAUER U. Neonates at risk of atopy show impaired production of interferon-gamma after stimulation with bacterial products (LPS and SEE) [see comments]. Allergy 1997: 52: 732-8.